DescriptionCOVID-19 - $50,025.05 FOR LIGHT SOURCE EXTRAORDINARY OPERATIONS IN RESPONSE TO COVID-19
PERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY. |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$43,373,338 |
DescriptionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$24,886,601 |
DescriptionNCI OPERATIONAL TASK ORDER |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$2,626,906 |
DescriptionCOVID-19 ADVANCE AGREEMENT UPDATE
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionCOVID-19 ADVANCE AGREEMENT EXTENSION
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionCOVID-19 MOD TO UPDATE ADVANCE AGREEMENT
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionNCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$1,283,576 |
DescriptionCOVID-19 CARES ACT EXTENSION
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionCOVID AGREEMENT EXTENSION
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionNCI OPERATIONAL TASK ORDER |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$400,000 |
DescriptionCOVID-19 UPDATE ADVANCE AGREEMENT MOD
OPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |
DescriptionNCI OPERATIONAL TASK ORDER |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$207,226,867 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$2,150,259 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$10,574,155 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$4,550,785 |
DescriptionFUNDING ONLY MODIFICATION WITH COVID-19 FUNDS FOR PERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY. |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$23,318,285 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$22,416,036 |
DescriptionPROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$5,070,370 |
DescriptionMANUFACTURE AND TESTING OF ZIKA VIRUS OR ZIKA-RELATED VIRUS VACCINE PRODUCTS.
COVID-19: ALCOHOL-BASED HAND SANITIZER WILL BE MANUFACTURED AND MADE AVAILABLE BASED ON CURRENT FDA POLICY ISSUED EARLY MARCH AND UPDATED ON MARCH 27, 2020. THE HAND SA |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveSeptember 20, 2017 |
Estimated completionSeptember 19, 2022 |
Amount Committed$0 |
DescriptionPERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY. |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$10,500,581 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$46,000,000 |
DescriptionPROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed-$393,000 |
DescriptionPROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |
DescriptionCOVID-19 - $1,500,000 LIGHT SOURCE EXTRAORDINARY OPERATIONS IN RESPONSE TO COVID-19
PERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY. |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$1,500,000 |
DescriptionNCI OPERATIONAL TASK ORDER
COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005
COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281 |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |
DescriptionOPERATIONS AND MANAGEMENT OF THE NASA BALLOON FACILITY |
VendorORBITAL SCIENCES CORPORATION |
AgencyNational Aeronautics and Space Administration |
EffectiveFebruary 01, 2015 |
Estimated completionSeptember 30, 2021 |
Amount Committed$0 |
DescriptionPERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY.
COVID-19 $480,000
COVID-19 $150,000
COVID-19 $2,350,000 |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$79,534,751 |
DescriptionCOVID-19 3610 - MANAGEMENT AND OPERATION OF THE NAVAL NUCLEAR LABORATORY |
VendorFLUOR MARINE PROPULSION, LLC |
AgencyDepartment of Energy |
EffectiveJuly 12, 2018 |
Estimated completionSeptember 30, 2028 |
Amount Committed-$500,000 |
DescriptionPERFORMANCE-BASED CONTRACT FOR MANAGEMENT AND OPERATION OF BROOKHAVEN NATIONAL LABORATORY. |
VendorBROOKHAVEN SCIENCE ASSOCIATES, LLC |
AgencyDepartment of Energy |
EffectiveJanuary 05, 2015 |
Estimated completionJanuary 04, 2025 |
Amount Committed$0 |
DescriptionMANUFACTURE AND TESTING OF ZIKA VIRUS OR ZIKA-RELATED VIRUS VACCINE PRODUCTS.
COVID-19: ALCOHOL-BASED HAND SANITIZER WILL BE MANUFACTURED AND MADE AVAILABLE BASED ON CURRENT FDA POLICY ISSUED EARLY MARCH AND UPDATED ON MARCH 27, 2020. THE HAND SA |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveSeptember 20, 2017 |
Estimated completionSeptember 19, 2022 |
Amount Committed$0 |
DescriptionPROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO |
VendorLEIDOS BIOMEDICAL RESEARCH, INC. |
AgencyNational Institutes of Health |
EffectiveAugust 31, 2020 |
Estimated completionAugust 30, 2024 |
Amount Committed$0 |